Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.
about
Glucose metabolism in gastric cancer: The cutting-edgeThe Warburg effect and drug resistanceLow dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt LymphomaAcquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer.Lysosomotropism depends on glucose: a chloroquine resistance mechanismAutophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes.miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy.Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids.The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1.B cell lymphoma with different metabolic characteristics show distinct sensitivities to metabolic inhibitors.Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment.
P2860
Q26766098-298649C1-B6DD-49D2-ABFD-2F01B1491228Q26770007-755106E0-85D8-46FF-8F9E-6B656F1421E9Q33761600-BBFC37E1-FCEB-4591-A958-DAB019980E88Q35696506-19A84DD3-701D-4D5C-92DB-0430143E9E30Q37301776-D06A9EE8-0234-425E-B0A1-5A730140B3FEQ38610330-45595675-38CC-4853-8188-4A6A38C3C84FQ38734363-DFB46ED3-848C-4687-9120-1F42F67390FFQ41471256-F95C6F84-13C1-4376-BAE9-8F8C2B553EFEQ47718581-A1CBC400-7A22-4B6A-A0CA-4BAF0105C0F3Q49515320-DC3C212A-E968-40C5-B699-206BBE59E922Q51451285-336C98D1-3916-4356-BCC0-40B7A725C639Q52671366-A0E40349-A06F-4AB4-8AB9-0A38D5BFA86FQ55279249-7859ACE1-8071-40B7-985F-836FBEA4D396Q55280857-C46CC491-5BA1-4D07-9B6C-D41075FE4CCEQ55396364-87E7AB50-B09F-4EF7-BDEC-955E2C608975
P2860
Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased drug resistance is a ...... enhanced glycolysis phenotype.
@en
type
label
Increased drug resistance is a ...... enhanced glycolysis phenotype.
@en
prefLabel
Increased drug resistance is a ...... enhanced glycolysis phenotype.
@en
P2093
P2860
P356
P1476
Increased drug resistance is a ...... enhanced glycolysis phenotype
@en
P2093
B Bhattacharya
M Beloueche-Babari
N Kamal Mustapa
P2860
P304
P356
10.1111/BPH.12668
P407
P50
P577
2014-07-01T00:00:00Z